Tert-Butylamine

Tert-Butylamine

SCHEMBL27701396

CC(C)(C)N.Nc1cc([N+](=O)[O-])ccn1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEIDH1

The experimentally established mechanism targets of Tert-Butylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 5/20 0.44
ALDH1A1 P00352 4/20 0.44
CYP3A4 P08684 3/20 0.44
TSHR P16473 4/20 0.43
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
NOS3 P29474 1/20 0.41
NOS1 P29475 1/20 0.41
NOS2 P35228 1/20 0.41
KMT2A Q03164 1/20 0.41
HTT P42858 1/20 0.41
ROCK1 Q13464 2/20 0.40
GAA P10253 1/20 0.40
THRB P10828 1/20 0.40
LMNA P02545 1/20 0.39
CDC7 O00311 1/20 0.39
PDE4D Q08499 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL345273 0.91 ALDH1A1 (0.48) TDP1ALDH1A1CYP3A4TSHRKDM4E
SCHEMBL3311690 0.91 ALDH1A1 (0.48) TDP1ALDH1A1CYP3A4TSHRKDM4E
SCHEMBL14200093 0.75 ALDH1A1 (0.43) TDP1ALDH1A1TSHRKDM4EMEN1
SCHEMBL30389430 0.74 ALDH1A1 (0.46) TDP1ALDH1A1CYP3A4TSHRGAA
SCHEMBL19214820 0.72 CYP3A4 (0.36) TDP1ALDH1A1CYP3A4TSHRMEN1
SCHEMBL23829919 0.72 ALDH1A1 (0.47) TDP1ALDH1A1CYP3A4TSHRGAA
SCHEMBL2144876 0.72 TSHR (0.50) TDP1ALDH1A1CYP3A4TSHRMEN1
SCHEMBL826630 0.71 TSHR (0.50) TDP1ALDH1A1CYP3A4TSHRKDM4E
SCHEMBL30749767 0.71 HSD17B10 (0.48) TDP1ALDH1A1CYP3A4TSHRKMT2A
SCHEMBL3638370 0.70 ALDH1A1 (0.52) ALDH1A1TSHRMEN1NOS3NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101180275-B Tetrahydroindolone and tetrahydroindazolone derivatives SERENEX INC 2014-09-10 CN disclosed
CN-101180275-A Tetrahydroindolone and tetrahydroindazolone derivatives SERENEX INC (US) 2008-05-14 CN disclosed